Oct 24 (Reuters) - Laboratory operator Labcorp (LH.N), opens new tab beat Wall Street estimates for third-quarter profit and revenue on Thursday as strong demand for diagnostic tests offset a hit from ...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.
(1) 2025 Updated guidance includes an impact from foreign currency translation of 0.4%. (2) Enterprise level revenue is presented net of intersegment transaction eliminations. (3) 2025 Updated ...
Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities and contract termination costs within the organization in connection ...
Labcorp Holdings Inc. LH, or Labcorp’s strong focus on key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, is poised to help it grow in the upcoming ...
Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities and contract termination costs within the organization in connection ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results